UnknownNCT01039766
The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of PTSD (PTSD)
This study evaluates the effectiveness of Oxytocin for people with PTSD.
Medication studyAges 18–67Israel
Understand this study
What is this study about?
This study evaluates the effectiveness of Oxytocin for people with PTSD.
Who could participate?
Listed age limits: 18 years to 67 years.
- Listed locations
- Ramat GanSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2010
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 24
- Sponsor
- Sheba Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- From 18 Years to 67 Years
- Official registry ID
- NCT01039766
- Official title
Show the full official title
The Efficacy of the Proximate Administration of Oxytocin After a Traumatic Event in Preventing the Development of Post Traumatic Stress Disorder
Recruitment & locations
Status unknownRamat Gan
A listed location does not confirm current availability.
Questions about this study
What is this study about?
This study evaluates the effectiveness of Oxytocin for people with PTSD.
Who is behind this study?
The study sponsor is Sheba Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Oxytocin and placebo - saline nasal spray.
Who can participate?
Listed age limits: 18 years to 67 years.
